![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 47, 44146-44156, November 23, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
,
,

From the Departments of
Physiology and
§ Pharmacology, University of Texas Southwestern Medical
Center, Dallas, Texas 75390, the ¶ Center for Basic Research in
Digestive Diseases, Mayo Clinic and Foundation,
Rochester, Minnesota 55905, the
Department of Pathology
and Laboratory Medicine and the ** Departments of Oral
Biology and Pharmacology and Therapeutics, University of Florida,
Gainesville, Florida 32610
Received for publication, June 6, 2001, and in revised form, August 28, 2001
| |
ABSTRACT |
|---|
|
|
|---|
In the present work we examined localization and
behavior of G protein-coupled receptors (GPCR) in polarized exocrine
cells to address the questions of how luminal to basal
Ca2+ waves can be generated in a receptor-specific
manner and whether quantal Ca2+ release reflects partial
release from a continuous pool or an all-or-none release from a
compartmentalized pool. Immunolocalization revealed that expression of
GPCRs in polarized cells is not uniform, with high levels of GPCR
expression at or near the tight junctions. Measurement of phospholipase
C Ca2+ signaling by G protein-coupled receptors
(GPCR)1 involves the
generation of inositol 1,4,5-trisphosphate (IP3) in the
cytosol and Ca2+ release from the endoplasmic reticulum
(1). In polarized exocrine cells, Ca2+ release is not
uniform but occurs in the form of Ca2+ waves. Rooney
et al. (2) reported a unique initiation site and propagation
pattern of GPCR-evoked Ca2+ waves in hepatocytes. Kasai
et al. (3) first described the unique feature of initiation
of Ca2+ waves at the apical pole and their propagation to
the basal pole of pancreatic acini. This phenomenon was later confirmed
in pancreatic acinar cells (3-6) and was extended to other exocrine
cells (7, 8). Subsequent studies showed that expression of high levels of all IP3 receptor (IP3Rs) isoforms at the
apical pole accounts for the initiation of Ca2+ waves at
this site (7, 9). Furthermore, the apical pole showed higher
sensitivity to Ca2+ release by IP3 than other
regions of the cell, including the basal pole (3, 10, 11). However,
since the discovery of the polarized Ca2+ waves in exocrine
cells, it remained a mystery how IP3 can be generated in
the apical pole to initiate the waves. Early functional (12) and
radioligand (13) localization of receptors in tissue slices indicated
that GPCRs are expressed in the basal membrane. Therefore, it was
assumed that during GPCR stimulation IP3 generated in the
basal pole diffuses to the apical pole to initiate Ca2+
release and waves (14). This assumption has several difficulties. For
example, at maximal stimulus intensity Ca2+ release starts
within few milliseconds of cell stimulation. The diameter of exocrine
acinar cells is about 20 µm. This requires exceptionally high rate of
diffusion of IP3 in the cytosol of this cells. In
pancreatic acini, Ca2+ release events can remain confined
to the apical pole (3, 4). This requires continuous traffic of
IP3 through the cytosol without causing Ca2+
release. Another alternative is generation of IP3 in or
close proximity to the apical pole. This requires localization of GPCR at the apical pole. With the development of suitable antibodies for
immunolocalization of GPCR and the use of isolated cell clusters that
increase the resolution of immunolocalization, it became possible to
re-examine GPCR localization in relation to initiation of
Ca2+ waves.
Another aspect of Ca2+ release in terms of initiation and
propagation of Ca2+ waves is the architecture of the
Ca2+ pool and the dynamics of Ca2+ release.
Propagation of Ca2+ waves requires either sequential
Ca2+ release from a compartmentalized pool or release from
different sections of a continuous pool along the path of the
Ca2+ wave. A unique property of Ca2+ release
from internal stores, the quantal feature of Ca2+ release
(15), can reflect the spatial organization of the Ca2+ pool
that is needed for propagation of Ca2+ waves.
Ca2+ release evoked by either stimulation of GPCR (15),
activation of the IP3 receptors (15-17), or activation of
the ryanodine receptors (18) has quantal properties, that is at
submaximal stimulus intensity only part of the Ca2+ pool is
released and at increased stimulus an increased fraction of the pool is
released. Two main models were proposed to explain quantal release. The
first is an all-or-none release of Ca2+ from a
compartmentalized pool that has a continuum of sensitivity to
IP3 (15, 19, 20). The second model proposes phasic
Ca2+ release from a homogeneous pool where the phase of
release at a given IP3 concentration is determined by
gating of IP3Rs activity by Ca2+ content
remaining in the stores (21). The first model fits well with the
experimentally observed variable sensitivity of different cellular
regions of pancreatic acini to IP3-mediated Ca2+ release (3, 11). On the other hand, recent work (22)
in Xenopus oocytes reports that the quantal behavior of
Ca2+ release stems from rapid adaptation of the
IP3R channels of a continuous Ca2+ pool and
claimed to refute the compartmentalization model.
The constancy of initiation of Ca2+ waves in the apical
pole by all GPCR of pancreatic acini and the variable sensitivity of different cellular regions to IP3-mediated Ca2+
release prompted us to determine localization of GPCR in pancreatic acini and to examine their autonomous behavior and what mechanism they
use to evoke quantal release. We report that expression of GPCR is
highly enriched in the apical pole, at or just underneath the tight
junctions. This provides an explanation of how Ca2+ waves
are initiated at the apical pole. The initiation site and propagation
pattern of Ca2+ waves are receptor-specific in the same
cells. This appears to be the result of autonomous coupling of
receptors to G proteins and thus operation of GPCR signaling complexes.
Finally and most notably, by using agonist concentration jump protocols
and inhibition of the sarco/endoplasmic reticulum
Ca2+-ATPase (SERCA) pump of partially stimulated cells, we
provide evidence that the quantal properties of Ca2+
release are due to an all-or-none Ca2+ release from a
compartmentalized Ca2+ pool.
Materials--
Thapsigargin was from Alexis. The anti-muscarinic
monoclonal antibody (mAb) M35 was from Argene. The hybridoma cells
producing the 5H9 mAb against muscarinic type 3 receptor (M3R) and the
specificity of the Abs were described elsewhere (23). Two pAbs that
recognize different epitopes of the cholecystokinin (CCK) receptor were prepared using peptide antigens, and their specificity was extensively characterized and verified by blocking with peptides that were used to
raise the anti-CCKR antibodies (24). A recombinant M2R was a generous
gift from Dr. Eliott Ross (University of Texas Southwestern Medical
Center, Dallas). Anti-IP3R2 pAb was a generous gift from
Dr. Akihiko Tanimura (University of Hokkaido, Ishikari-Tobetsu, Japan).
The box domain of RGS4 (4Box) was prepared as described (25).
Anti-IP3R3 mAb and anti ZO1 pAbs were purchased from ABR and Zymed Laboratories Inc., respectively. Anti-ZO1
mAb was obtained from the Hybridoma Bank at the University of Iowa.
Preparation of Pancreatic Acini and Single Acinar
Cells--
Acini were prepared from the pancreas of 100-150-g rats by
limited collagenase digestion as described previously (6). After isolation, the acini were resuspended in a standard solution A containing (in mM) 140 NaCl, 5 KCl, 1 MgCl2, 1 CaCl2, 10 Hepes (pH 7.4 with NaOH), 10 glucose, and 0.1%
bovine serum albumin and kept on ice until use. Doublet or triplet
acinar cell clusters were obtained by incubation of a minced pancreas
in a 0.025% trypsin, 0.02% EDTA solution for 5 min at 37 °C. After
washing with solution A supplemented with 0.02% soybean trypsin
inhibitor, doublets and triplets were liberated by a 7-min incubation
at 37 °C in the same solution that also contained 160 units/ml pure
collagenase. The cells were washed with solution A and kept on ice
until use.
[Ca2+]i Imaging--
Pancreatic acinar
cells were loaded with Fura 2, and [Ca2+]i was
imaged as detailed before (6). Fura 2 fluorescence was measured at a
single excitation wavelength of 380 nm, by averaging eight consecutive
images for each time point. Under these conditions and using a frame
size of 256 × 240 pixels, recording was at a resolution of 90 ms/averaged image. During perfusion with the control solution and just
before the first stimulation, the image of resting cells was acquired
and was taken as the fluorescence signal at time 0 (F0). Pixel values of all subsequent images were divided by this image, and the traces and images are the calculated Ft/F0, where
Ft is the fluorescence at time t.
To calculate the distance between initiation sites from which
Ca2+ waves were triggered by different agonists or
sequential application of the same agonist in the same cell, the
initiation sites of all waves were marked on the first image, and the
image was transferred to Adobe Photoshop. A right triangle was drawn
using the ray between the two initiation sites as the hypotenuse. The
x and y axes originated from the left and top
plane, respectively. The distance between the initiation sites was then
calculated by means of the Pythagorean theorem. The distances from
multiple experiments were averaged and are given as means ± S.E.
Although this procedure allowed quantitative analysis of the distance
between initiation sites, such analysis has limitations inherent
to the imaging procedure. The most critical limitation is the spatial
resolution of cell imaging. The initiation sites and the waves are
three-dimensional, whereas imaging at a speed needed to capture
Ca2+ waves can be done only in two dimensions.
Another limitation of the measurement is the temporal resolution
of our recording system. This resulted in initiation sites that occupy
1-2 µm2. Nevertheless, the differences in
Ca2+ wave initiation sites and propagation pattern observed
when cells were stimulated with two different agonists were
sufficiently large to allow quantitative analysis of our measurements.
Electrophysiology--
The whole cell configuration of the patch
clamp technique was used for measurement of Ca2+-activated
Cl Measurement of IP3--
IP3 levels were
measured by a radioligand assay as described elsewhere (28). Acini in
solution A were stimulated with the indicated combination of agonists
for 10 s at 37 °C. The reactions were stopped by addition of 20 µl of ice-cold 20% perchloric acid to 200 µl of samples, vigorous
mixing, and incubation on ice for at least 10 min to allow
precipitation of proteins. The supernatants were collected and
transferred to clean tubes. Standards of IP3 were prepared
in the same manner. The perchloric acid was removed and IP3
extracted by the addition of 0.15 ml of Freon and 0.15 ml of
tri-n-octylamine. IP3 content in the aqueous
phase was measured by displacement of [3H]IP3
using microsomes prepared from bovine brain cerebella (28).
Immunocytochemistry--
The immunostaining procedure was
described previously (29). In brief, cells attached to glass coverslips
were fixed and permeabilized with cold methanol. After removal of
methanol, nonspecific sites were blocked by a 1-h incubation in
blocking medium prior to incubation with 50 µl of blocking medium
containing control serum (controls) or the following antibodies: 1:500
dilution of the M35 mAb that recognizes all muscarinic receptors; the
same mAbs that were reabsorbed with recombinant M2R; 1:250 dilution of
the 5H9 mAb recognizing the M3R; 1:200 dilution of pAb specific for the
M3R; 1:50 dilution of pAb1 and a 1:100 dilution of pAb2 that recognize
the CCK receptor; 1:200 dilution of mAb against IP3R3;
1:100 dilution of pAb against IP3R2; 1:20 dilution of mAb against ZO1; and 1:100 dilution of pAb recognizing ZO1. After incubation with the various primary antibodies overnight at 4 °C,
the cells were washed three times with the incubation buffer. For the
experiment with the 5H9 mAbs in Fig. 4A, two different protocols were used. The first was a standard protocol using
permeabilized cells. Under these conditions, all pools of M3R were
detected. Because this antibody recognizes an extracellular epitope of
the M3R diagnostic of Sjögren syndrome (23), it was used to label the receptors in the plasma membrane by incubating a 0.5-ml suspension of intact cells with 50 µl of 5H9 mAb for 30 min at 37 °C. The cells were then washed 3 times with phosphate-buffered saline to remove
excess antibodies before fixation with 0.5 ml of cold methanol. All
steps post-fixation were the same as with permeabilized cells. The
primary Abs were detected with goat anti-rabbit or anti-mouse IgG
tagged with fluorescein or rhodamine. Images were collected with a
Bio-Rad MRC 1024 confocal microscope.
Receptor-specific Ca2+ Waves--
Repetitive
stimulation of pancreatic acinar cells with the same high concentration
of agonist evokes Ca2+ waves with the same initiation site
and propagation pattern (6). The quantal properties of agonist-mediated
Ca2+ release (15) raised the question of whether partial
and maximal discharge of the pool generates the same or different
Ca2+ waves. In particular, it was of interest to determine
whether the wave initiates from the same site at low and high
IP3 concentrations generated by weak and intense agonist
stimulation. The properties of Ca2+ waves evoked by
repetitive, brief stimulation with increasing concentration of agonist
(5, 50, and 500 µM carbachol) are depicted in Fig.
1. Similar results were obtained in seven
different cell preparations. All experiments were performed with
clusters of doublet or triplet cells to ensure polarized expression of
signaling protein was maintained. The arrowheads in the
first image of each series show that the initiation site is constant
and is independent of the IP3 concentration used to
initiate the wave. The calculated distance between initiation sites
(see "Experimental Procedures") averaged 0.19 ± 0.05 µm
(n = 7). The diameter of an acinar cell was about 20 µm. In addition, the pattern of wave propagation remained constant at
all agonist concentrations. Increased stimulation intensity only
increased the rate of Ca2+ wave propagation.
Constant initiation site and propagation patterns of Ca2+
waves were also observed with repetitive stimulation of another GPCR, the CCK receptor (see below). However, in previous work (6) we reported
that stimulations of multiple GPCRs in the same rat pancreatic acinar
cell evoked receptor-specific Ca2+ waves in terms of
initiation sites and propagation patterns. Cancela et al.
(30) used mouse pancreatic acinar cells to suggest that
Ca2+ waves are stochastic and are similar for all GPCRs in
a given cell. Therefore, we examined Ca2+ waves evoked by
carbachol and CCK stimulation in the same cell of small acinar
clusters. Fig. 2 shows three examples of
five experiments with similar results. The cells were stimulated with submaximal agonist concentrations to increase the temporal resolution of the waves. The white (carbachol) and magenta
(CCK) arrowheads in the first image of each experiment show
that, without exception, the initiation site of Ca2+ waves
was different between the two agonists. The calculated distance between
the carbachol and CCK initiation averaged 4.5 ± 1.5 µm (range
1.2-9.1 µm, n = 5). Although the waves initiated by
stimulation of the two receptors propagated along the cell periphery,
differences in wave patterns were noticeable in most experiments. Close
examination of the results in Fig. 5A of Cancela et
al. (30) also show that in a single isolated mouse pancreatic acinar cell activation of the muscarinic and CCK receptors resulted in
different initiation sites of Ca2+ waves. This is
particularly evident when the third image of the acetylcholine series
is compared with the second image of the CCK series. The
Ca2+ waves evoked by the two GPCRs had different spatial
propagation pattern.
Autonomous Behavior of Signaling Complexes--
The constancy of
Ca2+ waves evoked by repetitive stimulation of the same
GPCR, their independence of stimulus intensity, and the different
Ca2+ wave evoked by activation of different GPCRs in the
same cell suggest autonomous functioning of GPCRs. We used two
experimental protocols to test this prediction. In the first set of
experiments we examined IP3 production by maximal agonist
concentrations added individually or in combination. Although maximal
stimulation of each of the GPCRs can mobilize the entire
Ca2+ pool (see below), Fig.
3A shows that all combinations
of agonists produced a nearly additive increase in IP3
concentration. Hence, each GPCR can activate different pools of
cellular PLC
In the second protocol we used the RGS domain of RGS4 (4Box) to
demonstrate autonomous functioning of the GPCRs in the same cell. The
4Box lacks receptor recognition domain and is a poor inhibitor of
signaling in resting cells (31). The 4Box binds to activated
Polarized Expression of Ca2+ Signaling Proteins and
Receptors--
Polarized and restricted expression of Ca2+
channels and Ca2+ pumps in the luminal pole of epithelial
cells appears to be important for initiation and propagation of
polarized Ca2+ waves (7, 33). Co-immunoprecipitation of
various Ca2+ signaling proteins indicates organization of
the proteins into complexes in cellular microdomains (29). GPCRs are
believed to be expressed mostly in the basal membrane. However, a
recent report (34) suggested the possible expression of selective GPCRs next the luminal pole in rat goblet cells. With the development of
selective antibodies that recognize several GPCRs, it was of interest
to re-examine localization of GPCRs in pancreatic acini. Fig.
4 demonstrates the co-localization of the
type 3 muscarinic (M3Rs) and CCK receptors (CCKRs) with
Ca2+-signaling proteins. Both receptors are expressed at
high levels at the apical pole of pancreatic acini. Several antibodies
used to localize the M3Rs revealed two cellular pools of these
receptors, a plasma membrane and a Golgi-like pools. Double staining
with pAb recognizing M3Rs and ZO1, a specific tight-junction protein (Fig. 4A, top panels), or IP3R2 (not shown)
showed that M3Rs localized in a non-uniform fashion with high levels at
the lateral border, in close proximity or at the tight junctions, and
low levels at the basal region (n = 10). However, the
M35 and the 5H9 mAbs showed different patterns of localization. In
permeabilized cells, the two mAbs showed strong labeling of an
intracellular compartment and lower staining of the plasma membrane
(n = 9 for M35, n = 6 for 5H9). This is
particularly evident with the M35 mAb (Fig. 4, lower middle
panel). The staining with this mAb was eliminated by adsorbing the
mAb with recombinant M2Rs (Fig. 4, lower left panel),
demonstrating specificity of the Abs. Because the 5H9 mAbs recognize an
extracellular epitope evident of Sjögren syndrome (23), the
plasma membrane staining was isolated by incubating intact cells with
the Ab prior to cell fixation and permeabilization. Fig. 4A,
lower right panel, shows that the M3Rs receptors are highly
localized to the lateral membrane next to tight junctions (n = 4).
Selective localization was also observed with the CCKRs using two
different pAbs recognizing different domains of the receptor, a pAb
raised against amino acids 30-42 and a pAb raised against amino acids
411-429 of the type A CCKR (24). The two Abs specifically recognized
recombinant and native CCKRs. Localization of the CCKRs at the apical
pole of the lateral membrane (Fig. 4B) was similar to that
of the M3Rs at the plasma membrane. The CCKRs at the plasma membrane
were concentrated very near the IP3R3 at the apical pole (n = 10). The anti-CCKRs Abs did not recognize a Golgi
pool of this receptor.
Quantal Behavior and an All-or-None Ca2+
Release--
The independence of the Ca2+ waves initiation
site and propagation pattern of IP3 concentration (Fig. 1)
offered us the opportunity to examine whether local Ca2+
release is due to an all-or-none release from a compartmentalized pool
(Fig. 5, model A) or a partial
release from a continuous pool (Fig. 5, model B). The
experiments used to distinguish between the two models and their
predicted outcome according to each model are depicted in Fig. 5.
Resting cells are in state a. Shortly after cell stimulation
with submaximal agonist concentration (state b), all the
Ca2+ is released from a sub-compartment of the pool
(model A) or part of the Ca2+ is released from
the entire pool (model B). At continuous stimulation (state c), high [Ca2+]i at the mouth
of the IP3Rs reduces channel activity to allow partial
reloading of the just discharged sub-pool with Ca2+ by the
activated SERCA pumps (35) (model A). In this scenario, Ca2+ permeability of the sub-pool remains elevated, whereas
Ca2+ permeability of the remaining pool is similar to that
in resting cells. By contrast, model B assumes that at
continuous stimulation, the activity of all the IP3Rs
channels is adapted to the lower Ca2+ content in the entire
pool to terminate Ca2+ release so that Ca2+
permeability of the pool is similar to that of resting cells.
The first protocol we used is an agonist concentration jump after state
c, long after return of [Ca2+]i to near resting
level. Model A predicts that the agonist (or IP3)
concentration jump will generate a Ca2+ wave with the same
initiation site and pattern. Model B predicts generation of
Ca2+ waves from random initiation sites and propagation
pattern, because of the adaptation of the IP3Rs that
generated the first wave. Fig. 6 shows
the results of such experiments with carbachol and CCK. It is clear
that the Ca2+ waves initiated by low agonist and the
concentration jump have the same initiation site and propagation
pattern. In five experiments with carbachol and four experiments with
CCK, the average distances between the two initiation sites were
0.16 ± 0.03 and 0.10 ± 0.03 µm, respectively. Localized
generation of IP3 due to the polarized expression of the
muscarinic receptors is likely to contribute to the constancy of the
wave. Hence, in addition to testing the first prediction in Fig. 5, the
constancy of the wave observed with the protocol of Fig. 6 lend further
support for the autonomous behavior of signaling complexes
In the second protocol, the second Ca2+ wave was initiated
by applying the concentration jump at the end of Ca2+
release evoked by the low agonist and before any reduction in [Ca2+]i due to IP3Rs channel
adaptation. Model A predicts a second Ca2+ wave with
different initiation site, due to discharge of all the Ca2+
from the pool mobilized by low agonist. Model B predicts a second Ca2+ wave from the same initiation site because
Ca2+ is released prior to adaptation of the
IP3Rs activated by the first stimulus. The trace
in Fig. 7 shows that this particular cell
was exposed to the supermaximal concentration of 5 mM
carbachol at 1.63 s after simulation with 5 µM
carbachol. The concentration of 5 mM was used for the
second stimulus, which was applied by rapid injection from a needle
adjacent to the cell, to minimize the delay between agonist application
and cell stimulation. The images in Fig. 7 show the results of four of
five independent experiments with similar results. In contrast with the
prediction of model B, but as predicted by model A, in all experiments
the second Ca2+ wave evoked by the agonist concentration
jump was initiated at a different site than the first Ca2+
wave. The calculated distance between the initiation sites averaged 7.3 ± 1.3 µm (range 3.3-10.9 µm, n = 5),
which is statistically different (p < 0.01) from the
0.19 ± 0.05 µm measured after delayed application of
carbachol.
A shift in the initiation site of Ca2+ waves when the
second wave was initiated at the end of the first Ca2+
release (Fig. 7) can be either because the initiation site still contained Ca2+ but the IP3Rs at this site
became refractory to a jump in IP3 concentration, or
because all the Ca2+ was released from this site by the
first stimulus, and Ca2+ re-uptake is needed to initiate a
second Ca2+ wave from the same site. The results in Fig.
8 provide direct evidence that
Ca2+ release is an all-or-none process and that
Ca2+ uptake must occur to initiate multiple
Ca2+ waves from the same site. In these experiments we
blocked the SERCA pumps with 10 µM thapsigargin (Tg) at
different times after initiation of a Ca2+ wave. Model A
predicts that inhibition SERCA pumps of cells continuously stimulated
with low agonist at any time will trigger a Ca2+ wave with
the same initiation site and pattern. Model B predicts that inhibition
of SERCA pumps will not trigger a wave but rather will cause slow
Ca2+ release because of adaptation of all
IP3Rs. Fig. 8A shows that in the absence of
agonist stimulation, Tg caused a slow, peripheral to central
Ca2+ release with no apparent Ca2+ wave or
preferential release from any cellular region. As shown by the
trace in Fig. 8A, [Ca2+]i
continued to increase for at least 30 s after exposure to Tg.
Hence, in the absence of agonist stimulation Tg never initiated a
Ca2+ wave.
Very different results were obtained when the cells were stimulated
with submaximal agonist concentration and allowed to reduce [Ca2+]i back to near basal level. As shown in
Fig. 8B, under these conditions Tg evoked rapid, luminal to
basal Ca2+ waves. Remarkably, in all experiments the
Tg-evoked Ca2+ waves had the same initiation site and
propagation pattern as the first Ca2+ wave evoked by the
agonists. The distance between the initiation sites of the first waves
evoked by carbachol and the second waves evoked by Tg in the same cells
averaged 0.25 ± 0.1 µm (n = 5), which is not
different from the 0.16 ± 0.03 µm measured with delayed concentration jump. The traces in C show that the magnitude
of Ca2+ release by Tg was dependent on the incubation time
with agonist. Thus, simultaneous stimulation of the cells with 5 µM carbachol and 10 µM Tg resulted in a
rapid Ca2+ release but slow return of
[Ca2+]i to basal levels, much slower than the
rate observed with agonist alone (compare red to all
other traces in C). Application of Tg at different times
after cell stimulation caused a rapid increase in
[Ca2+]i, to approximately the same level as that
caused by the agonist and a slow reduction toward basal levels. Hence,
Tg rapidly discharged only the Ca2+ that was incorporated
into the initiation site during continuous stimulation and never to a
level significantly higher than the initial level caused by the
agonists. This behavior indicates that Ca2+ release from
the initiation site must be an all-or-none process and that the
initiation site reloads with Ca2+ during continuous
stimulation with submaximal agonist concentration (model A).
Furthermore, this behavior is incompatible with model B.
In the present work we addressed two important topics in
Ca2+ signaling: how luminal to basal Ca2+ waves
can be generated in a receptor-specific manner and whether quantal
Ca2+ release reflects partial release from a continuous
pool or an all-or-none release from a compartmentalized pool. Polarized
exocrine cells are a good model system to address these questions
because of the polarized nature of their Ca2+ signals (3),
the polarized expression of high levels of Ca2+ transport
proteins in the apical pole (7, 9, 29, 33, 36), and the generation of
receptor-specific Ca2+ signals in these cells (6, 37). Our
results indicate that signaling specificity in pancreatic acinar cells
is aided by polarized expression and autonomous functioning of GPCRs
and that quantal Ca2+ release is due to an all-or-none
Ca2+ release from a compartmentalized Ca2+ pool.
Signaling specificity is a central topic in cell signaling (38).
Several mechanisms have been shown to contribute to generation of
specific GPCR-dependent Ca2+ signals, which
include selective phosphorylation of IP3Rs (39), differential couplings of Ca2+ release to Ca2+
entry (40), and different involvement of cADP-ribose and
NADP-mediated Ca2+ release in the response (30). However,
ultimately signaling specificity must reside in the communication
between the receptor and downstream effectors. Indeed, RGS proteins
function in a receptor-specific manner to confer receptor-specific
signaling (41). Interaction of receptors with effectors requires their
co-localization in cellular microdomains at sites of Ca2+
release. In polarized exocrine cells Ca2+ waves are always
initiated at the apical pole. Whereas expression of all known
IP3R isoforms (7, 9), specific isoforms of SERCA pumps
(33), and plasma membrane Ca2+ ATPase pumps (36) has
been demonstrated, it remains a puzzle as to how IP3 can be
generated at this cellular microdomain because GPCRs are believed to
reside largely at the basal pole. The localization of the M3Rs and
CCKRs found at the present work clarifies this issue. The use of three
anti-M3Rs and two anti-CCKRs, which recognize different epitopes,
showed that both GPCR types are expressed at high level at close
proximity or at the tight junctions. This localization removes the need
to assume long range diffusion of IP3 from the basal to the
apical pole to initiate Ca2+ waves. Moreover, such
localization of GPCRs is likely to contribute to the constancy of the
Ca2+ waves generated by repetitive stimulation of the same
GPCR complex.
In the present work we confirmed and extended the finding of
receptor-specific Ca2+ waves by various GPCRs expressed in
the same cell. By using the unique property of recruitment and trapping
of the 4Box within signaling complexes (27), we demonstrated autonomous
functioning of GPCRs. Furthermore, production of IP3 by
multiple GPCRs was nearly additive. The combined findings indicate that
different GPCRs communicate with separate portions of the cellular pool of G Since the discovery of the quantal behavior of Ca2+ release
(15), two models were proposed as possible mechanisms of this phenomenon (see Fig. 5). The first model proposes that the
intracellular Ca2+ pool is compartmentalized with respect
to Ca2+ release, and the IP3R
Ca2+ release channels in the different compartments
have variable affinity to IP3 and Ca2+ release
from individual compartments in an all-or-none process (15, 20). The
second model proposed that the intracellular Ca2+ pool is
continuous, and the affinity of all IP3Rs to
IP3 is the same but is sensitive to Ca2+
content in the stores, and Ca2+ release is incremental due
to rapid inactivating adaptation of the IP3Rs (21). The
evidence in favor of the adaptation model is the finding that stored
Ca2+ regulates the affinity of the IP3Rs for
IP3 in virtually all cell types examined (42), and a recent
report (22) indicates that two rapid successive increases in
IP3 can liberate Ca2+ from the same site. The
first evidence (42) is not mutually exclusive with the all-or-none
model, and in the second case (22) rapid Ca2+ re-uptake
into the stores was not prevented by inhibition of the SERCA pumps
which, as shown in the present work, can explain the second
Ca2+ release event.
Previous evidence in support of the all-or-none model was developed by
measurement of Ca2+ permeability of the stores at
increasing stimulus intensity (15). Increased agonist concentration
mobilized a larger fraction of the Ca2+ pool. At persistent
stimulation with submaximal agonist concentrations, Ca2+
permeability of the mobilized fraction of the pool remained very high,
whereas Ca2+ permeability of the immobilized fraction
remained very low, identical to that measured in resting cells (15).
Another important finding in support of the all-or-none model is the
variable sensitivity of IP3 to Ca2+ release
from different regions of pancreatic acinar cells (3, 11). The
adaptation model predicts uniform IP3 sensitivity
throughout the cell.
In the present work we provide what we believe is strong evidence in
support of the all-or-none model by first showing that the initiation
site of Ca2+ waves is independent of IP3
concentration. The implication of this finding is that there must exist
a sub-pool that is more sensitive to IP3 than the remaining
cellular Ca2+ pool, and this pool is always discharged
first upon cell stimulation. This provides additional evidence that the
cellular Ca2+ pool is not uniform with respect to
sensitivity to IP3. Next, we used an agonist concentration
jump to apply two consecutive rapid or delayed applications of
IP3. This protocol is equivalent to the two consecutive
IP3 application protocols used to conclude multiple
Ca2+ release events from the same site (22). Two
consecutive applications of IP3 in pancreatic acini
released Ca2+ from two separate sites when the second
application was applied immediately at the end of Ca2+
release by the first application (Fig. 7). The difference between our
results and those obtained in Xenopus oocytes (22) can be due to species differences or partial reloading of the just released pool with Ca2+.
The adaptation model requires that at continued exposure to the same
IP3 concentration, the IP3R channels adapt,
becoming refractory to IP3, and Ca2+
permeability of the pool is reduced back to resting level to terminate
Ca2+ release. We used Tg to provide compelling evidence
that this is not the case, at least in pancreatic acini. In
fact, the Ca2+ pool liberated by submaximal receptor
stimulation reloads with Ca2+ with continuous exposure to a
constant agonist concentration. Furthermore, and most important, the
Ca2+ permeability of the released and reloaded pool remains
high, resulting in a Tg-evoked Ca2+ wave. The Tg-evoked
Ca2+ wave had the same initiation site and propagation
pattern as the Ca2+ wave evoked by the agonist (Fig. 8).
Hence, the maintained high Ca2+ permeability of the
liberated sub-pool, reloading of the sub-pool at continued stimulation,
and the shift in the initiation site of Ca2+ wave observed
at rapid agonist concentration jump are all compatible only with an
all-or-non model of Ca2+ release. Therefore, we conclude
that the principal mechanism behind the quantal behavior of
Ca2+ release is an all-or-none Ca2+ release
from highly compartmentalized intracellular Ca2+ pool.
activity and receptor-dependent recruitment and
trapping of the box domain of RGS4 in GPCRs complexes indicated
autonomous functioning of Gq-coupled receptors in acinar cells. These findings explain the generation of receptor-specific Ca2+ waves and why the waves are always initiated at the
apical pole. The initiation site of Ca2+ wave at the apical
pole and the pattern of wave propagation were independent of inositol
1,4,5-trisphosphate concentration. Furthermore, a second
Ca2+ wave with the same initiation site and pattern was
launched by inhibition of sarco/endoplasmic reticulum
Ca2+-ATPase pumps of cells continuously stimulated with
sub-maximal agonist concentration. By contrast, rapid sequential
application of sub-maximal and maximal agonist concentrations to the
same cell triggered Ca2+ waves with different initiation
sites. These findings indicate that signaling specificity in pancreatic
acinar cells is aided by polarized expression and autonomous
functioning of GPCRs and that quantal Ca2+ release is not
due to a partial Ca2+ release from a continuous pool, but
rather, it is due to an all-or-none Ca2+ release from a
compartmentalized Ca2+ pool.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
current, which correlates with changes in
[Ca2+]i near the plasma membrane (26). The
experiments were performed with single acinar cells perfused with
solution A. The standard pipette solution contained the following (in
mM): 140 KCl, 1 MgCl2, 0.5 EGTA, 5 ATP, 10 Hepes (pH 7.3 with KOH) with or without 100 nM 4Box, as
described in previous studies (27). The 4Box was dialyzed against an
ATP-free pipette solution and concentrated to about 5 µM
with a centricone system. Seals of 6-10 gigohms were produced on the
cell membrane, and the whole cell configuration was obtained by gentle
suction or voltage pulses of 0.5 V for 0.3-1 ms. The patch clamp
output (Axopatch-1B, Axon Instruments) was filtered at 20 Hz. Recording
was performed with patch clamp 6 and a Digi-Data 1200 interface (Axon
Instruments). All traces shown were recorded at a holding potential of
40 mV.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (97K):
[in a new window]
Fig. 1.
Ca2+ wave initiation site
and pattern are independent of [IP3]. Fura 2-loaded
doublet or triplet cell clusters were stimulated with 5, 50, and 500 µM carbachol. The cells were perfused with solution A for
3 min between the stimulations. The top left bright field
image is × 600 magnification and the middle image
is × 1000 magnification of the cell marked by an
asterisk. The top right image shows the Fura 2 ratio under resting conditions. The first image in each row shows the
first detected [Ca2+]i increase by the respective
carbachol concentration. The arrowheads mark the exact same
spot in each image, demonstrating the same initiation site at all
carbachol concentrations. The sequential images show the identical
Ca2+ wave patterns at all carbachol concentrations. The
bottom panel show the changes in
Ft/F0 ratios during the
[Ca2+]i rise phase for the three carbachol
concentrations. Traces 1-5 show the
[Ca2+]i changes in the areas marked
1-5 in the bright-field image. Please note the different
times at top left of each sequence of images and the
different time scales for the traces at each agonist concentration,
demonstrating the effect of increased agonist concentration on the
speed of the wave. AM, apical membrane; BM, basal
membrane; SG, secretory granule; N,
nucleus.

View larger version (103K):
[in a new window]
Fig. 2.
Receptor-specific initiation site and
propagation pattern of Ca2+ waves. Cells were
sequentially stimulated with 5 µM carbachol and 0.25 nM CCK, as indicated in the traces in the
upper panel. A shows the initiation site and
pattern of the Ca2+ wave evoked by activation of the two
receptors in the same cell. B and C show
additional examples of the different Ca2+ wave initiation
sites evoked by carbachol (white arrowhead) and CCK
(magenta arrowhead) stimulation in the same cells.
AM, apical membrane; BM, basal membrane.
or distinct portions of a single pool that is in excess
to the total number of GPCRs.

View larger version (29K):
[in a new window]
Fig. 3.
Autonomous behavior of GPCR complexes.
A shows stimulation of IP3 production by 1 mM carbachol (Car), 10 nM CCK8b, and
100 nM BS alone (open column) and combinations
of two (gray columns) or the three agonists (filled
column). B-E show the Ca2+-activated
Cl
current recorded from control cells or cells dialyzed
with 100 nM 4Box for 7 min before the first stimulation.
The bars indicate where the cells were stimulated with the
indicated agonist concentration. Note that CCK8 and BS had no effect on
[Ca2+]i in carbachol-stimulated cells under
control conditions but evoked a maximal response in cells dialyzed with
4Box.
-subunits of G proteins (25, 32) and is nearly as effective as
full-length RGS4 in stimulating GTPase activity of G
q
(31). Consequently, upon cell stimulation the 4Box is recruited
to signaling complexes to inhibit their activity and remains trapped in
the complexes for as long as the cells are stimulated (see Ref. 27 for
further details on the mode of action of the 4Box). We took advantage
of the mode of interaction of the 4Box with GPCR signaling complexes to
examine whether maximal activation of one GPCR type is sufficient to
recruit 4Box to all GPCRs complexes, or stimulation of each GPCR
complex is needed to inhibit signaling of the stimulated complex. Fig.
3, B and C, shows that stimulation of cells with
1 mM carbachol resulted in complete mobilization of the
Ca2+ pool, as evident from the failure of 10 nM
CCK8 and 100 nM bombesin (BS) to increase
[Ca2+]i in cells continuously stimulated with
carbachol. When the cells were infused with 100 nM 4Box,
stimulation with 1 mM carbachol resulted in a maximal
initial signal that terminated rapidly and returned to base line at
continuous stimulation with carbachol, due to
receptor-dependent recruitment and trapping of 4Box (27).
Fig. 3, D and E, shows that at continuous
stimulation with carbachol the cells responded with a maximal signal to
CCK8 (n = 15) and BS stimulation (n = 4). The response to CCK8 and BS had the same kinetics as that to
carbachol, with a rapid onset and inhibition, and it remained inhibited
for the duration of cell stimulation. This behavior is best explained
if the various receptors are coupled to separate pools of cellular
G
q and PLC
.

View larger version (44K):
[in a new window]
Fig. 4.
Polarized expression of GPCRs, ZO1, and
IP3Rs. Isolated pancreatic acini were fixed and
stained with the following Abs: A, upper panels,
double staining with anti-ZO1 and anti-M3Rs; middle panels,
double staining with anti-ZO1 and the anti-M3R mAb clone 5H9 after cell
permeabilization; lower left panel, staining with the
anti-muscarinic receptors mAb M35 pre-adsorbed with recombinant M2
receptors; middle panels, double staining with anti-M3Rs
clone M35 and anti-ZO1; lower right panel, staining with
anti-M3Rs mAb clone 5H9 in intact cells before permeabilization (see
"Experimental Procedures"). B, main panels, double
staining with anti-CCKRs raised against amino acids 411-429 of the
CCKR and anti-ZO1 or anti-IP3R2, as indicated; right
panel, staining with an Ab that was raised against amino acids
30-42 of the CCKR.

View larger version (30K):
[in a new window]
Fig. 5.
Models of quantal Ca2+
release. Model A illustrates quantal Ca2+
release by an all-or-none mechanism and model B
Ca2+ release by IP3Rs adaptation mechanism. The
text depicts the predicted outcomes of the agonist concentration jump
and SERCA pump inhibition protocols by each model.

View larger version (105K):
[in a new window]
Fig. 6.
Successive stimulation by a delayed agonist
concentration jump. A, the cell was stimulated with 5 µM carbachol, and after return of Ca2+ to
basal levels carbachol concentration was rapidly increased to 0.5 mM. B, the cell was stimulated with 0.25 nM CCK, and after return of Ca2+ to resting
levels CCK concentration was increased to 10 nM. The
white arrowheads show the Ca2+ wave initiation
site for each stimulation period. Note the same initiation site by the
low and high agonist concentrations in all experiments.

View larger version (97K):
[in a new window]
Fig. 7.
Successive stimulation by a rapid agonist
concentration jump. The trace shows the experimental
protocol and the Ft/F0 ratio
of a typical experiment. The cells were stimulated with 5 mM carbachol at the peak of the
[Ca2+]i increase evoked by 5 µM
carbachol. The images in A-D show the initiation site of
the Ca2+ waves evoked by rapid, consecutive application of
5 µM (white arrowhead) and 5 mM
carbachol (magenta arrowhead) to the same cells. Note the
different initiation sites by the low and high agonist concentrations
in all experiments.

View larger version (82K):
[in a new window]
Fig. 8.
Ca2+ waves are evoked by
inhibition of SERCA pumps in cells continuously stimulated with low
agonist concentration. A, maximal inhibition of SERCA
pumps by 10 µM thapsigargin (Tg) in resting
cells causes a slow peripheral to central Ca2+ release.
B, maximal inhibition of SERCA pumps by Tg in cells
continuously treated with 5 µM carbachol after return of
[Ca2+]i to basal level launch a Ca2+
wave with the same initiation site (white arrowheads) and
propagation pattern as the initial wave evoked by carbachol.
C, cells were stimulated with 5 µM carbachol
(a) or 0.25 nM CCK (b). At different
times during the reduction of [Ca2+]i to basal
levels, SERCA pumps were inhibited with 10 µM Tg. In all
cases Tg evoked a rapid increase in [Ca2+]i (in
the form of a luminal-to-basal Ca2+ wave) with a subsequent
slow reduction in [Ca2+]i.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
q and PLC
to generate IP3 at separate
cellular microdomains. The finding that the initiation site of
Ca2+ waves was independent of IP3
concentration, remaining constant when initiated by low (weak
stimulation) or high IP3 concentration (intense agonist
stimulation), indicates that each GPCR communicates with a separate
portion of the Ca2+ pool at the apical pole to generate
Ca2+ waves with distinct initiation sites. Communication
with a distinct portion of the Ca2+ pool may also reflect
localized generation of IP3 at the locus from which
Ca2+ waves are initiated. Measurement of IP3 in
single pancreatic acinar cells is needed to test this point. At
present, this is not feasible.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: the University of
Texas Southwestern Medical Center, Dallas, 5323 Harry Hines Blvd.,
Dallas, TX 75390-9040. Tel.: 214-648-2593; Fax: 214-648-8879; E-mail:
SHMUEL.MUALLEM@utsouthwestern.edu.
Published, JBC Papers in Press, September 11, 2001, DOI 10.1074/jbc.M105203200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: GPCR, G protein-coupled receptors; IP3, inositol 1,4,5-trisphosphate; IP3R, IP3 receptor(s); SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; PLC, phospholipase C; M3R, muscarinic type 3 receptor; Ab, antibody; mAb, monoclonal antibody; pAb, polyclonal antibody; CCK, cholecystokinin; BS, bombesin; CCK, CCK receptor(s); Tg, thapsigargin.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berridge, M. J. (1993) Nature 361, 315-325[CrossRef][Medline] [Order article via Infotrieve] |
| 2. |
Rooney, T. A.,
Sass, E. J.,
and Thomas, A. P.
(1990)
J. Biol. Chem.
265,
10792-10796 |
| 3. | Kasai, H., Li, Y. X., and Miyashita, Y. (1993) Cell 74, 669-677[CrossRef][Medline] [Order article via Infotrieve] |
| 4. | Thorn, P., Lawrie, A. M., Smith, P. M., Gallacher, D. V., and Petersen, O. H. (1993) Cell 74, 661-668[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Nathanson, M. H.,
Fallon, M. B.,
Padfield, P. J.,
and Maranto, A. R.
(1994)
J. Biol. Chem.
269,
4693-4696 |
| 6. |
Xu, X.,
Zeng, W.,
Diaz, J.,
and Muallem, S.
(1996)
J. Biol. Chem.
271,
24684-24690 |
| 7. |
Lee, M. G.,
Xu, X.,
Zeng, W.,
Diaz, J.,
Wojcikiewicz, R. J.,
Kuo, T. H.,
Wuytack, F.,
Racymaekers, L.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
15765-15770 |
| 8. | Takemura, H., Yamashina, S., and Segawa, A. (1999) Biochem. Biophys. Res. Commun. 259, 656-660[CrossRef][Medline] [Order article via Infotrieve] |
| 9. |
Yule, D. I.,
Ernst, S. A.,
Ohnishi, H.,
and Wojcikiewicz, R. J.
(1997)
J. Biol. Chem.
272,
9093-9098 |
| 10. |
Ito, K.,
Miyashita, Y.,
and Kasai, H.
(1999)
J. Cell Biol.
146,
405-413 |
| 11. |
Fogarty, K. E.,
Kidd, J. F.,
Tuft, D. A.,
and Thorn, P.
(2000)
J. Physiol. (Lond.)
526,
515-526 |
| 12. | Williams, J. A., Groblewski, G. E., Ohnishi, H., and Yule, D. I. (1997) Digestion 58, 42-45 |
| 13. |
Roettger, B. F.,
Rentsch, R. U.,
Hadac, E. M.,
Hellen, E. H.,
Burghardt, T. P.,
and Miller, L. J.
(1995)
J. Cell Biol.
130,
579-590 |
| 14. | Kasai, H., and Petersen, O. H. (1994) Trends Neurosci. 17, 95-101[CrossRef][Medline] [Order article via Infotrieve] |
| 15. |
Muallem, S.,
Pandol, S. J.,
and Beeker, T. G.
(1989)
J. Biol. Chem.
264,
205-212 |
| 16. |
Meyer, T.,
and Stryer, L.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
3841-3845 |
| 17. |
Bootman, M. D.,
Berridge, M. J.,
and Taylor, C. W.
(1992)
J. Physiol. (Lond.)
450,
163-178 |
| 18. |
Koizumi, S.,
Lipp, P.,
Berridge, M. J.,
and Bootman, M. D.
(1999)
J. Biol. Chem.
274,
33327-33333 |
| 19. |
Totorici, G.,
Zhang, B.-X.,
Xu, X.,
and Muallem, S.
(1994)
J. Biol. Chem.
269,
29621-29628 |
| 20. | Taylor, C. W. (1992) Adv. Second Messenger Phosphoprotein Res. 26, 109-142[Medline] [Order article via Infotrieve] |
| 21. | Missiaen, L., Parys, J. B., De Smedt, H., Oike, M., and Casteels, R. (1994) Mol. Cell. Endocrinol. 98, 147-156[CrossRef][Medline] [Order article via Infotrieve] |
| 22. | Callamaras, N., and Parker, I. (2000) EMBO J. 19, 3608-3617[CrossRef][Medline] [Order article via Infotrieve] |
| 23. | Nguyen, K. H., Brayer, J., Cha, S., Diggs, S., Yasunari, U., Hilal, G., Peck, A. B., and Humphreys-Beher, M. G. (2000) Arthritis Rheum. 43, 2297-2306[CrossRef][Medline] [Order article via Infotrieve] |
| 24. |
Fischer de Toledo, C.,
Roettger, B. F.,
Morys-Wortmann, C.,
Schmidt, W. E.,
and Miller, L. J.
(1997)
Am. J. Physiol.
272,
G488-G497 |
| 25. |
Popov, S., Yu, K.,
Kozasa, T.,
and Wilkie, T. M.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
7216-7220 |
| 26. |
Zeng, W.,
Xu, X.,
and Muallem, S.
(1996)
J. Biol. Chem.
271,
18520-18526 |
| 27. | Luo, X., Popov, S., Bera, A. M., Wilkie, T. M., and Muallem, S. (2001) Mol. Cell 7, 651-660[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Zhang, B. X.,
Tortorici, G.,
Xu, X.,
and Muallem, S.
(1994)
J. Biol. Chem.
269,
17132-17135 |
| 29. |
Shin, D. M.,
Zhao, X. S.,
Zeng, W.,
Mozhayeva, M.,
and Muallem, S.
(2000)
J. Cell Biol.
150,
1101-1112 |
| 30. | Cancela, J. M., Gerasimenko, O. V., Gerasimenko, J. V., Tepikin, A. V., and Petersen, O. H. (2000) EMBO J. 19, 2549-2557[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Zeng, W.,
Xu, X.,
Popov, S.,
Mukhopadhyay, S.,
Chidiac, P.,
Swistok, J.,
Fisher, S. L.,
Ross, E. M.,
Muallem, S.,
and Wilkie, T. M.
(1998)
J. Biol. Chem.
273,
34687-34690 |
| 32. | Tesmer, J. J., Berman, D. M., Gilman, A. G., and Sprang, S. R. (1997) Cell 89, 251-261[CrossRef][Medline] [Order article via Infotrieve] |
| 33. |
Lee, M. G.,
Xu, X.,
Zeng, W.,
Diaz, J.,
Kuo, T. H.,
Wuytack, F.,
Racymaekers, L.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
15771-15776 |
| 34. |
Rios, J. D.,
Zoukhri, D.,
Rawe, I. M.,
Hodges, R. R.,
Zieske, J. D.,
and Dartt, D. A.
(1999)
Ophthalmol. Vis. Sci.
40,
1102-1111 |
| 35. | Muallem, S., Beeker, T. G., and Fimmel, C. J. (1987) Biochem. Biophys. Res. Commun. 149, 213-220[CrossRef][Medline] [Order article via Infotrieve] |
| 36. | Zhao, X.-S., Shin, D. M., Liu, L. H., Shull, G. E., and Muallem, S. (2001) EMBO J. 20, 2680-2689[CrossRef][Medline] [Order article via Infotrieve] |
| 37. | Yule, D. I., Lawrie, A. M., and Gallacher, D. V. (1991) Cell Calcium 12, 145-151[CrossRef][Medline] [Order article via Infotrieve] |
| 38. | Hunter, T. (2000) Cell 100, 113-127[CrossRef][Medline] [Order article via Infotrieve] |
| 39. |
LeBeau, A. P.,
Yule, D. I.,
Groblewski, G. E.,
and Sneyd, J.
(1999)
J. Gen. Physiol.
113,
851-872 |
| 40. | Xu, X., Zeng, W., Diaz, J., Lau, K. S., Gukovskaya, A. C., Brown, R. J., Pandol, S. J., and Muallem, S. (1997) Cell Calcium 22, 217-228[CrossRef][Medline] [Order article via Infotrieve] |
| 41. |
Xu, X.,
Zeng, W.,
Popov, S.,
Berman, D. M.,
Davignon, I., Yu, K.,
Yowe, D.,
Offermanns, S.,
Muallem, S.,
and Wilkie, T. M.
(1999)
J. Biol. Chem.
274,
3549-3556 |
| 42. | Missiaen, L., De Smedt, H., Droogmans, G., and Casteels, R. (1992) Nature 357, 599-602[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
J. G. McCarron, S. Chalmers, and T. C. Muir `Quantal' Ca2+ release at the cytoplasmic aspect of the Ins(1,4,5)P3R channel in smooth muscle J. Cell Sci., January 1, 2008; 121(1): 86 - 98. [Abstract] |